Working toward reducing schizophrenia relapse
Schizophrenia is a chronic, relapsing, and disabling disorder characterized by symptoms such as hallucinations and delusions, disorganized thinking, affective flattening, apathy, and social withdrawal.1 Schizophrenia is characterized by recurrent episodes of relapse of psychotic symptoms.1
The risk of relapse is great, with the one-year rate as high as 50 percent and the five-year rate as high as 80 percent.2,3 Prevention of relapse is one crucial goal of long-term therapy in schizophrenia.4
Frameworks in Health and Quality: Schizophrenia Relapse Reduction Program is a series of educational resources for healthcare stakeholders — including providers and payers who can choose to share resources with patients and their caregivers — that aims to:
- Assist and complement relapse reduction efforts
- Enhance communication among all stakeholders
- Provide stakeholders with relapse educational materials for patients and caregivers
- Emphasize patient wellness and adherence to treatment plans
- Promote other important relapse reduction topics such as medication reconciliation, transitions of care, and quality measures
Because relapse in schizophrenia is associated with a heavy financial and human burden, its reduction has become an important goal. Our Frameworks in Health and Quality: Schizophrenia Relapse Reduction disease management program can complement your efforts by providing resources to key stakeholders who are in a position to help improve the quality of care delivered to patients.
Program introductory materials and key issues for payers including Healthcare Effectiveness Data and Information Set (HEDIS®) quality improvement guidance resources and disease management program components.
Fictional Case Study in Schizophrenia: Long-acting Injectable Antipsychotics as a Treatment Option — Anton
Fictional Case Study in Schizophrenia: Long-acting Injectable Antipsychotics as a Treatment Option — Jenny
Program introductory materials and education and awareness resources for providers, community mental health centers, case managers, hospital treatment teams, social workers, and other patient advocates; including relapse and disease management, treatment adherence, and medication reconciliation resources.
Program materials include schizophrenia and relapse education and awareness resources that include tools for relapse action planning, treatment adherence, and hospitalization resources.
*Frameworks resources use patient and consumer interchangeably.
- American Psychiatric Association. Depressive disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013:155-188.
- Robinson D, Woerner MG, AIvir JM, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999;56(3):241-247.
- Schennach R, Naber D, Ruther E, et al. Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatr Serv. 2012;63(1):87-90.
- Lehman AF, Lieberman JA, Dixon, LB, et al; for the Work Group on Schizophrenia, American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia. II. Formulation and Implementation of a Treatment Plan. Arlington, VA: American Psychiatric Publishing, Inc; 2004.